| Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ... Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013 | 615 | 2013 |
| Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ... Cancer cell 27 (4), 516-532, 2015 | 451 | 2015 |
| The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ... The Journal of experimental medicine 209 (9), 1537, 2012 | 434 | 2012 |
| Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia D Rossi, H Khiabanian, V Spina, C Ciardullo, A Bruscaggin, R Famà, ... Blood, The Journal of the American Society of Hematology 123 (14), 2139-2147, 2014 | 430 | 2014 |
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia D Rossi, V Spina, R Bomben, S Rasi, M Dal-Bo, A Bruscaggin, FM Rossi, ... Blood, The Journal of the American Society of Hematology 121 (24), 4902-4905, 2013 | 161 | 2013 |
| Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia F Arruga, B Gizdic, S Serra, T Vaisitti, C Ciardullo, M Coscia, L Laurenti, ... Leukemia 28 (5), 1060-1070, 2014 | 147 | 2014 |
| Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. D Rossi, S Rasi, V Spina, M Fangazio, S Monti, M Greco, C Ciardullo, ... British journal of haematology 158 (3), 2012 | 132 | 2012 |
| MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia L De Paoli, M Cerri, S Monti, S Rasi, V Spina, A Bruscaggin, M Greco, ... Leukemia & lymphoma 54 (5), 1087-1090, 2013 | 122 | 2013 |
| Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies D Rossi, C Ciardullo, G Gaidano Seminars in cancer biology 23 (6), 422-430, 2013 | 80 | 2013 |
| High‐throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications M Lionetti, S Fabris, G Cutrona, L Agnelli, C Ciardullo, S Matis, G Ciceri, ... British journal of haematology 165 (5), 629-639, 2014 | 69 | 2014 |
| Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia S Rasi, H Khiabanian, C Ciardullo, L Terzi-di-Bergamo, S Monti, V Spina, ... Haematologica 101 (4), e135, 2016 | 46 | 2016 |
| Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. M Greco, D Capello, A Bruscaggin, V Spina, S Rasi, S Monti, C Ciardullo, ... Hematological oncology 31 (1), 54-55, 2012 | 38 | 2012 |
| Ibrutinib-naive chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance R Famà, R Bomben, S Rasi, M Dal Bo, C Ciardullo, S Monti, F Rossi, ... Blood, The Journal of the American Society of Hematology 124 (25), 3831-3833, 2014 | 36 | 2014 |
| Inter‐and intra‐patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments I Del Giudice, M Marinelli, J Wang, S Bonina, M Messina, S Chiaretti, ... British journal of haematology 172 (3), 371-383, 2016 | 31 | 2016 |
| Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells C Ciardullo, E Aptullahoglu, L Woodhouse, WY Lin, JP Wallis, H Marr, ... Haematologica 104 (12), 2429, 2019 | 26 | 2019 |
| Molecular bases of chronic lymphocytic leukemia in light of new treatments D Rossi, C Ciardullo, V Spina, G Gaidano Immunology Letters 155 (1-2), 51-55, 2013 | 22 | 2013 |
| Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 … M Oliveira, D Pominchuk, EP Hamilton, Y Kulyaba, T Melkadze, P Neven, ... Journal of Clinical Oncology 41 (16_suppl), 1066-1066, 2023 | 13 | 2023 |
| Liquid biopsy as a tool for monitoring the genotype of diffuse large B-cell lymphoma S Rasi, S Monti, M Zanni, C Ciardullo, F Diop, L Martuscelli, ... Blood 126 (23), 127, 2015 | 10 | 2015 |
| Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia C Ciardullo, K Szoltysek, P Zhou, M Pietrowska, L Marczak, E Willmore, ... Cancers 14 (1), 23, 2021 | 9 | 2021 |
| DAP kinase-related apoptosis-inducing protein kinase 2 (DRAK2) is a key regulator and molecular marker in chronic lymphocytic leukemia K Szoltysek, C Ciardullo, P Zhou, A Walaszczyk, E Willmore, V Rand, ... International Journal of Molecular Sciences 21 (20), 7663, 2020 | 9 | 2020 |
